Celularity Inc. - Class A (CELU)
CELU moved a median of -0.54% 30 minutes after news, and -0.89% by the close. How CELU actually reacts to news — the realized, point-in-time move the market made, measured across 253 labeled events over the last three years with zero look-ahead.
CELU’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 40% | 230 |
| 30-min | -0.54% | 38% | 243 |
| 60-min | 0.00% | 47% | 249 |
| to close | -0.89% | 42% | 248 |
| Middle 50% of CELU reactions | -2.40% to +2.18% |
|---|---|
| Median reaction (30-min) | -0.54% |
| Measured reactions | 253 |
Half of all Celularity Inc. - Class A news events land between -2.40% and +2.18% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when CELU moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to CELU's baseline. Nothing else.
Recent CELU events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner | Press release | GlobeNewswire | — | -0.73% | |
| Celularity Announces Naveen Jain to Join Board of Directors | Press release | GlobeNewswire | +1.44% | -0.72% | |
| Form 10-Q Celularity Inc For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.46% | -1.46% | |
| Form 8-K Celularity Inc For: Sep 29 | SEC filing · Form 8-K | SEC EDGAR | -1.46% | -1.46% | |
| Form 8-K Celularity Inc For: Sep 18 | SEC filing · Form 8-K | SEC EDGAR | +1.91% | +0.00% | |
| Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements | Press release | GlobeNewswire | +9.83% | +12.82% | |
| Form 8-K Celularity Inc For: Sep 11 | SEC filing · Form 8-K | SEC EDGAR | +5.21% | +6.06% | |
| Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform | Press release | Business Wire | -7.26% | +90.91% | |
| Celularity Provides Update Regarding Nasdaq Listing Compliance | Press release | GlobeNewswire | -2.50% | +10.05% | |
| Form NT 10-Q Celularity Inc For: Jun 30 | SEC filing · Form NT | SEC EDGAR | +0.00% | +2.35% | |
| Form 8-K Celularity Inc For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | +8.09% | — | |
| Form 8-K Celularity Inc For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Celularity Inc For: Jun 26 | SEC filing · Form 8-K | SEC EDGAR | -4.31% | +0.32% | |
| Form 8-K Celularity Inc For: Jun 19 | SEC filing · Form 8-K | SEC EDGAR | -2.63% | -3.13% | |
| Form 8-K Celularity Inc For: Jun 09 | SEC filing · Form 8-K | SEC EDGAR | — | +6.94% | |
| Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies | Press release | GlobeNewswire | +0.00% | -5.24% | |
| Celularity Appoints Rick Gonzalez as Chief Commercial Officer | Press release | GlobeNewswire | +1.92% | -1.92% | |
| Celularity Releases CEO Letter to Shareholders | Press release | GlobeNewswire | +0.00% | -5.24% | |
| Form 8-K Celularity Inc For: May 29 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -5.24% | |
| Celularity Receives Nasdaq Notice Regarding Form 10-Q | Press release | GlobeNewswire | -0.99% | +5.94% | |
| Form 8-K Celularity Inc For: May 21 | SEC filing · Form 8-K | SEC EDGAR | -1.96% | -0.98% | |
| Form NT 10-Q Celularity Inc For: Mar 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | -1.19% | |
| Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation | Press release | GlobeNewswire | -4.76% | -6.28% | |
| Form 10-K Celularity Inc For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +3.39% | -6.18% | |
| Celularity Announces Closing of Transaction with NexGel | Press release | GlobeNewswire | +1.57% | -3.94% | |
| Form 8-K Celularity Inc For: Apr 09 | SEC filing · Form 8-K | SEC EDGAR | +1.57% | -3.94% | |
| Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing | Press release | GlobeNewswire | +3.89% | +0.81% | |
| Form NT 10-K Celularity Inc For: Dec 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | -1.50% | |
| Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities | Press release | GlobeNewswire | +0.81% | +2.42% | |
| Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy | Press release | GlobeNewswire | +8.62% | +19.83% | |
| Form 8-K Celularity Inc For: Mar 06 | SEC filing · Form 8-K | SEC EDGAR | +8.62% | +19.83% | |
| Form 8-K Celularity Inc For: Feb 27 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.54% | |
| Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses | Press release | GlobeNewswire | — | +0.00% | |
| Form 8-K Celularity Inc For: Jan 16 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.67% | |
| Form EFFECT Celularity Inc | SEC filing · Form EFFECT | SEC EDGAR | -2.35% | +0.00% | |
| Form S-1 Celularity Inc | SEC filing · Form S-1 | SEC EDGAR | +0.89% | +9.01% | |
| Form EFFECT Celularity Inc | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -6.25% | |
| Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations | Press release | GlobeNewswire | +3.89% | +1.51% | |
| Form 8-K Celularity Inc For: Dec 19 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +4.76% | |
| Celularity Announces Closing of Financing Transactions | Press release | GlobeNewswire | +1.51% | -2.27% | |
| Form 8-K Celularity Inc For: Dec 19 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -8.97% | |
| Form S-1 Celularity Inc | SEC filing · Form S-1 | SEC EDGAR | +0.00% | -8.97% | |
| Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision | Press release | GlobeNewswire | -0.44% | -4.21% | |
| Form 8-K Celularity Inc For: Dec 05 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.54% | |
| Form 10-Q Celularity Inc For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.59% | -9.52% | |
| Form ARS Celularity Inc For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | — | +5.96% | |
| Form DEF 14A Celularity Inc For: Nov 07 | SEC filing · Form DEF | SEC EDGAR | +0.59% | +6.59% | |
| Form DEFA14A Celularity Inc | SEC filing · Form DEFA14A | SEC EDGAR | +0.59% | +5.96% | |
| Form S-8 Celularity Inc | SEC filing · Form S-8 | SEC EDGAR | — | +0.00% | |
| Form D Celularity Inc | SEC filing · Form D | SEC EDGAR | +0.58% | -0.58% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the CELU section they belong to.
Where else CELU is measured.
CELU earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Celularity Inc. - Class A's median reaction calculated?
Every labeled CELU news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 253 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 38% of CELU's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does CELU's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.